183 related articles for article (PubMed ID: 37974056)
1. Genomic, phenotypic, and clinical safety of Limosilactobacillus reuteri ATCC PTA 4659.
Sendelius M; Axelsson J; Liu P; Roos S
J Ind Microbiol Biotechnol; 2023 Feb; 50(1):. PubMed ID: 37974056
[TBL] [Abstract][Full Text] [Related]
2. In silico, in vitro and in vivo safety evaluation of Limosilactobacillus reuteri strains ATCC PTA-126787 & ATCC PTA-126788 for potential probiotic applications.
Gangaiah D; Mane SP; Tawari NR; Lakshmanan N; Ryan V; Volland A; Susanti D; Patel M; Abouzeid A; Helmes EB; Kumar A
PLoS One; 2022; 17(1):e0262663. PubMed ID: 35081129
[TBL] [Abstract][Full Text] [Related]
3. Genome-scale insights into the metabolic versatility of Limosilactobacillus reuteri.
Luo H; Li P; Wang H; Roos S; Ji B; Nielsen J
BMC Biotechnol; 2021 Jul; 21(1):46. PubMed ID: 34330235
[TBL] [Abstract][Full Text] [Related]
4. Removal of antibiotic resistance gene-carrying plasmids from Lactobacillus reuteri ATCC 55730 and characterization of the resulting daughter strain, L. reuteri DSM 17938.
Rosander A; Connolly E; Roos S
Appl Environ Microbiol; 2008 Oct; 74(19):6032-40. PubMed ID: 18689509
[TBL] [Abstract][Full Text] [Related]
5. Glycerol strengthens probiotic effect of Limosilactobacillus reuteri in oral biofilms: A synergistic synbiotic approach.
Van Holm W; Verspecht T; Carvalho R; Bernaerts K; Boon N; Zayed N; Teughels W
Mol Oral Microbiol; 2022 Dec; 37(6):266-275. PubMed ID: 36075698
[TBL] [Abstract][Full Text] [Related]
6. Exploring metabolic pathway reconstruction and genome-wide expression profiling in Lactobacillus reuteri to define functional probiotic features.
Saulnier DM; Santos F; Roos S; Mistretta TA; Spinler JK; Molenaar D; Teusink B; Versalovic J
PLoS One; 2011 Apr; 6(4):e18783. PubMed ID: 21559529
[TBL] [Abstract][Full Text] [Related]
7.
Maya-Barrios A; Lira-Hernandez K; Jiménez-Escobar I; Hernández L; Ortiz-Hernandez A; Jiménez-Gutiérrez C; López-Velázquez G; Gutiérrez-Castrellón P
Benef Microbes; 2021 Apr; 12(2):137-145. PubMed ID: 33789556
[TBL] [Abstract][Full Text] [Related]
8. Probiotic Lactobacillus reuteri strains ATCC PTA 5289 and ATCC 55730 differ in their cariogenic properties in vitro.
Jalasvuori H; Haukioja A; Tenovuo J
Arch Oral Biol; 2012 Dec; 57(12):1633-8. PubMed ID: 23010217
[TBL] [Abstract][Full Text] [Related]
9. Lactobacillus reuteri ATCC 55730 and L22 display probiotic potential in vitro and protect against Salmonella-induced pullorum disease in a chick model of infection.
Zhang D; Li R; Li J
Res Vet Sci; 2012 Aug; 93(1):366-73. PubMed ID: 21764090
[TBL] [Abstract][Full Text] [Related]
10. Lactobacillus reuteri-specific immunoregulatory gene rsiR modulates histamine production and immunomodulation by Lactobacillus reuteri.
Hemarajata P; Gao C; Pflughoeft KJ; Thomas CM; Saulnier DM; Spinler JK; Versalovic J
J Bacteriol; 2013 Dec; 195(24):5567-76. PubMed ID: 24123819
[TBL] [Abstract][Full Text] [Related]
11. The probiotic and immunomodulation effects of
Huang K; Shi W; Yang B; Wang J
Front Cell Infect Microbiol; 2022; 12():1086861. PubMed ID: 36710979
[TBL] [Abstract][Full Text] [Related]
12. Genomic and genetic characterization of the bile stress response of probiotic Lactobacillus reuteri ATCC 55730.
Whitehead K; Versalovic J; Roos S; Britton RA
Appl Environ Microbiol; 2008 Mar; 74(6):1812-9. PubMed ID: 18245259
[TBL] [Abstract][Full Text] [Related]
13. Transferability of a tetracycline resistance gene from probiotic Lactobacillus reuteri to bacteria in the gastrointestinal tract of humans.
Egervärn M; Lindmark H; Olsson J; Roos S
Antonie Van Leeuwenhoek; 2010 Feb; 97(2):189-200. PubMed ID: 19997864
[TBL] [Abstract][Full Text] [Related]
14. Identification of a proton-chloride antiporter (EriC) by Himar1 transposon mutagenesis in Lactobacillus reuteri and its role in histamine production.
Hemarajata P; Spinler JK; Balderas MA; Versalovic J
Antonie Van Leeuwenhoek; 2014 Mar; 105(3):579-92. PubMed ID: 24488273
[TBL] [Abstract][Full Text] [Related]
15. Heat-killed Limosilactobacillus reuteri ATCC PTA 6475 prevents bone loss in ovariectomized mice: A preliminary study.
Ribeiro JL; Santos TA; Garcia MT; Carvalho BFDC; Esteves JECS; Moraes RM; Anbinder AL
PLoS One; 2024; 19(5):e0304358. PubMed ID: 38820403
[TBL] [Abstract][Full Text] [Related]
16. Histamine derived from probiotic Lactobacillus reuteri suppresses TNF via modulation of PKA and ERK signaling.
Thomas CM; Hong T; van Pijkeren JP; Hemarajata P; Trinh DV; Hu W; Britton RA; Kalkum M; Versalovic J
PLoS One; 2012; 7(2):e31951. PubMed ID: 22384111
[TBL] [Abstract][Full Text] [Related]
17. Genes Involved in Galactooligosaccharide Metabolism in Lactobacillus reuteri and Their Ecological Role in the Gastrointestinal Tract.
Rattanaprasert M; van Pijkeren JP; Ramer-Tait AE; Quintero M; Kok CR; Walter J; Hutkins RW
Appl Environ Microbiol; 2019 Nov; 85(22):. PubMed ID: 31519661
[TBL] [Abstract][Full Text] [Related]
18. Culturing the Chicken Intestinal Microbiota and Potential Application as Probiotics Development.
Ma K; Chen W; Lin XQ; Liu ZZ; Wang T; Zhang JB; Zhang JG; Zhou CK; Gao Y; Du CT; Yang YJ
Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769368
[TBL] [Abstract][Full Text] [Related]
19. Human-derived probiotic Lactobacillus reuteri demonstrate antimicrobial activities targeting diverse enteric bacterial pathogens.
Spinler JK; Taweechotipatr M; Rognerud CL; Ou CN; Tumwasorn S; Versalovic J
Anaerobe; 2008 Jun; 14(3):166-71. PubMed ID: 18396068
[TBL] [Abstract][Full Text] [Related]
20. Human-derived probiotic Lactobacillus reuteri strains differentially reduce intestinal inflammation.
Liu Y; Fatheree NY; Mangalat N; Rhoads JM
Am J Physiol Gastrointest Liver Physiol; 2010 Nov; 299(5):G1087-96. PubMed ID: 20798357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
